- ►diabetesjournals.org BJ Lamont, DJ Drucker - Diabetes, 2008 - Am Diabetes Assoc RESULTS AND CONCLUSIONS— Mice treated with vehicle alone or DA-GIP exhibited
progressive weight gain, whereas treatment with Ex-4 or DPP-4i prevented weight
gain. Although Ex-4 improved oral glucose tolerance and insulin-to-glucose ... Cited by 17 - Related articles - BL Direct - All 5 versions
- ►glucagon.com [PDF] JE Ayala, DP Bracy, T Hansotia, G Flock, Y … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Compared with wild-type mice, chow and high fat–fed DIRKO mice
exhibited decreased fat and muscle mass associated with increased energy
expenditure and ambulatory activity. Clamp rates of glucose infusion (GIR), ... Cited by 9 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org G Flock, LL Baggio, C Longuet, DJ Drucker - Diabetes, 2007 - Am Diabetes Assoc RESULTS—Vildagliptin had no significant effect on food intake, energy
expenditure, body composition, body weight gain, or insulin sensitivity in WT or
DIRKO mice. However, glycemic excursion after oral glucose challenge was ... Cited by 12 - Related articles - BL Direct - All 4 versions
R Jorde, HL Waldum, PG Burhol, I Lygren, TB … - Scandinavian journal of gastroenterology, 1981 - ncbi.nlm.nih.gov Six healthy men were given a standard breakfast, one day with and another day
without a 2-h 100 micrograms/h somatostatin infusion. During the somatostatin
infusion the meal-induced responses of plasma GIP and serum insulin were ... Cited by 5 - Related articles
M Salera, L Pironi, P Giacomoni, S Venturi, M … - Digestion, 1982 - content.karger.com The effect of intravenous somatostatin infusion on circulating gastric
inhibitory polypeptide (GIP), insulin, glucagon and on blood glucose was
investigated in 7 healthy volunteers in the fasting state and during the ... Cited by 6 - Related articles - All 4 versions
B Ahren, S Lindskog, G Van Dijk, AJ Scheurink … - Endocrine research, 1995 - ncbi.nlm.nih.gov The truncated glucagon-like peptide-1 (GLP-1(7-36)amide or GLP-1) stimulates
insulin secretion, enhances glucose elimination and is of potential interest in
diabetes treatment. We studied the hypoglycemic action of GLP-1 in normal ... Cited by 7 - Related articles - BL Direct - All 3 versions
- ►nih.gov T Hansotia, A Maida, G Flock, Y Yamada, K … - Journal of Clinical Investigation, 2006 - Am Soc Clin Investig The incretin hormones glucagon-like peptide–1 (GLP-1) and glucose-dependent
insulinotropic polypeptide (GIP) control glucose homeostasis through
well-defined actions on the islet β cell via stimulation of insulin ... Cited by 54 - Related articles - BL Direct - All 9 versions
[CITATION] Differential hypothalamic neuronal activation after peripheral injection of GLP-1 and …
OB Chaudhri, JR Parkinson, YT Kuo, MR Druce … - Biochem Biophys Res Commun, 2006 Cited by 2 - Related articles
- ►endojournals.org K Azuma, Z Radikova, J Mancino, FGS Toledo, … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Objective: Pharmacological inhibition with the dipeptidyl peptidase 4 (DPP-4)
inhibitor vildagliptin prolongs the action of endogenously secreted incretin
hormones leading to improved glycemic control in patients with type 2 ... Cited by 24 - Related articles - BL Direct - All 4 versions
- ►physiology.org ET Parlevliet, AC Heijboer, JP Schroder-van … - American Journal of Physiology- Endocrinology And …, 2008 - Am Physiological Soc We evaluated the acute effects of OXM on glucose metabolism in diet-induced
insulin-resistant male C57Bl/6 mice. To determine the effects on glucose
tolerance, mice were intraperitoneally injected with OXM (0.75, 2.5, or 7.5 ... Cited by 4 - Related articles - BL Direct - All 3 versions
